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1. Introduction
Non-viral delivery systems usually include mechanical, electrical, and chemical methods.
Cationic liposomes and cationic polymers are two typical classes of non-viral vectors. Com‐
pared with viral vectors, non-viral ones are considered promising vehicles for gene therapy
because of their low toxicity, biocompatibility, and controllability [1, 2], although their low
efficacy limits their application as a mature gene delivery system. Improving the efficacy of
non-viral vectors necessitates thorough understanding of their in vivo key steps. Non-viral
vectors can complex with gene materials and help them access the target compartments
within cells. Many barriers prevent gene materials from reaching their intended target and
performing their functions [3], safe and effective delivery remains an important challenge
for the clinical development of non-viral vectors [4].
The delivery of pDNA or siRNA in vivo for therapeutic aims has been widely studied in re‐
cent years. However, non-viral delivery systems, which exhibit relatively low levels of effi‐
ciency, are not clinically applicable. Improving their efficiency is the main task of pDNA- or
siRNA-based gene therapy. There are many barriers that hinder pDNA and siRNA from
reaching their intended target in the plasma and performing their functions: First, gene ma‐
terials can be loaded into vectors. After in vivo administration, the vectors must be delivered
to the blood vessels and should be stable in the blood; otherwise, they will be cleared by al‐
bumin because of their high surface charge and may also be uptaken by macrophages. The
vectors must then pass through the epithelial tissue of the blood vessels and enter the target
tissue. As it is very difficult for nanoparticles larger than 5 nm in diameter to pass through
the epithelial tissue of blood vessels [5], it is crucial to study the cellular transport mecha‐
nism of epithelial cells through the caveolin-mediated endocytosis (CvME) pathway which
is active in epithelial cells [6]. The distance between the extracellular matrix and target cells
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is great, and many vectors will be uptaken and cleared by macrophages after they do man‐
age to pass through the epithelial tissue of blood vessels.
Next, the vectors must attach to the cell membrane, which entails other issues altogether.
First, the non-viral vectors should be able to identify specific cell types to ensure safety.
They then enter cells mainly via endocytosis. Different endocytosis pathways yield different
intracellular fates for vectors, which could potentially explain why the same vector differs in
its transfection efficiency in various cell modes. After their entry into the cells, vectors must
escape from the endosome or avoid the endo-lysosomal (endosomal and lysosomal) path‐
way through certain endocytosis pathways. After escaping the endosome and then entering
the cytoplasm, vectors must release pDNA or siRNA and finally perform their function in
the cytoplasm [5]. In addition, pDNA has to be transported into the nucleus. The key steps
in non-viral delivery are shown in Figure 1.
Figure 1. Biological key steps of non-viral vectors
As discussed above, the cellular process (including uptake, transport, endosomal escape,
and nuclear localization) is one of the most important steps for non-viral gene delivery. In
2001, Hideyoshi Harashima et al. stated that novel strategies of medical treatments, such as
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gene therapy, highlight the importance of studying the intracellular fate of macromolecules,
such as DNA and siRNA. In particular, in the case of gene therapy, intracellular events
would be expected to be the major factors controlling the fate of the introduced gene and the
efficiency of its expression. These authors attempted to establish an intracellular pharmaco‐
kinetic model of genes to study the intracellular events involved in gene therapy [7]. Under‐
standing the intracellular fate of a gene or vector is important for us to overcome the cellular
barriers of DNA or siRNA delivery and rationally design efficient systems thereof.
Of all intracellular events, the cellular uptake mechanism of non-viral vectors is the most es‐
sential to their efficiency and intracellular fate. Different cellular uptake pathways have dif‐
ferent intracellular fates. As the gene materials will be degraded in the endo-lysosomes
(endosomes and lysosomes). One good example is that some endocytic pathways involve
endo-lysosomes, but others that can bypass the endo-lysosomes have higher levels of deliv‐
ery efficiency. Polyethylenimine (PEI) is one of the most promising non-viral vectors [8].
Some researchers have shown that cellular uptake of PEI polyplexes affects other cellular
processes and, consequently, transfection efficiency [9, 10]. These differences may depend
on such factors as the size, surface properties, and shape of the particles [11], as well as dif‐
ferent cell lines [9].
Research has shown that polyplexes and lipoplexes have different uptake mechanisms in
A549 pneumocytes and HeLa cells. Lipoplex uptake proceeds only by clathrin-mediated en‐
docytosis (CME), whereas polyplexes are taken up by two mechanisms — one involving
caveolae and another using clathrin-coated pits [10]. As the caveolae-mediated uptake
mechanism has slower kinetics, the transfection process of polyplexes is slower than that of
lipoplexes in A549 pneumocytes and HeLa cells. However, as the polyplexes uptaken via
the caveolae escape the lysosomal compartment, polyplexes have a high level of transfection
efficiency [10]. Taken together, these findings highlight the importance of studying the cellu‐
lar uptake of non-viral vectors, their intracellular fate, and their effects on transfection effi‐
ciency. Understanding cellular uptake mechanisms is crucial to engineering successful
reagents or vectors for non-viral gene transfection [12].
2. Cellular uptake pathways of non-viral gene delivery
The uptake pathways are divided into two groups: endocytic pathways and non-endocytic
pathways. Inside endocytic group, there are two types of pathways: phagocytosis and non-
phagocytosis pathways [11].
2.1. Phagocytosis
Phagocytosis is a special type of endocytic pathway which primarily exists in professional
phagocytes such as macrophages, monocytes neutrophils, and dendritic cells (DCs) [13]. In
comparison, other nonphagocytic pathways such as clathrin-mediated endocytosis (CME),
caveolae-mediated endocytosis (CvME), and macropinocytosis occur in almost all kinds of
cell types [14]. Phagocytic pathway is mediated by cup-like membrane extensions that are
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usually larger than 1 μm to internalize large particles such as bacteria or dead cells. Under‐
standing of the mechanism of phagocytosis is very helpful to the non-viral gene therapy of
macrophage-dominated immune diseases such as rheumatoid arthritis. In addition, a phag‐
ocytosis-like mechanism was proposed for the uptake of large lipoplexes and polyplexes
that are larger than can be taken up by the classic CME pathway [15, 16].
Phagocytosis depending on opsonins can be called as opsonic phagocytosis. There is also
another phagocytosis which is opsonins independent. This will be discussed later. First, for
opsonic phagocytosis, the complexes will be recognized by opsonins in the bloodstream.
Then, the opsonized complexes adhere to professional phagocytes and are ultimately ingest‐
ed by them [11]. Opsonization is the key step of the phagocytosis pathway. It involves com‐
plexes tagged by some major opsonins including immunoglobulins G and M (IgG and IgM),
as well as complement components C3, C4, and C5 in the bloodstream [11, 17]. These opson‐
ized complexes become visible to macrophages and bind to their surface through the inter‐
action between receptors (such as fragment crystallizable receptors (FcR) and complement
receptors (CR)) and the constant fragment of particle-adsorbed immunoglobulins.
Other receptors that mediate phagocytosis pathway have also been reported. Mannose re‐
ceptor (MR) has been used in gene vaccine by targeting human DCs and macrophages
through the phagocytic pathway [18]. Scavenger receptor (SR)-mediated delivery of anti‐
sense miniexon phosphorothioate oligonucleotide to leishmania-infected macrophages is
proved to be selective and efficient in eliminating the parasite [19]. SR-A, macrophage recep‐
tor, and CD36 are the three SR subtypes. CD36 can mediate non-opsonic phagocytosis of
pathogenic microbes [20]. Unlike opsonic phagocytosis, non-opsonic phagocytosis is directly
mediated by the receptors on the cell surface without the help of opsonins. This kind of
mechanism can also be used for gene delivery.
Then the activated Rho-family GTPases trigger actin assembly and cell surface extension for‐
mation. This surface extension finally zippers up around the complexes and engulfs them
[11]. The phagosomes carrying the complexes fuse with lysosomes to form mature phagoly‐
sosomes [11]. In phagolysosomes, the complexes undergo a process of acidification and en‐
zymatic reaction. As the intracellular fate of phagocytosis is the transportation of complexes
into the lysosome, the gene materials will be degraded by the nucleases inside it [21]. Endo‐
somes and lysosomes (endo-lysosomes) are very important biological barrier for gene deliv‐
ery. The vectors should have capability to escape form them, if gene materials loaded
vectors entry into the cell via phagocytosis. The mechanisms of endo-lysosome escape will
be discussed later.
2.2. Non- phagocytosis pathways
Non- phagocytosis pathways mainly include clathrin-mediated endocytosis (CME), caveo‐
lae-mediated endocytosis (CvME), and macropinocytosis. CME is the best-characterized
type of endocytosis, which is receptor-dependent, clathrin-mediated, and GTPase dynamin-
required [22, 23]. The uptake of low-density lipoprotein and transferrin is typically via this
endocytic pathway, and they are often used as the CME probes in many studies [24, 25].
Transferrin has also been used as a ligand of non-viral vectors to improve the endocytosis of
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complexes [26, 27]. In this pathway, a series of downstream events are activated after the
recognition of ligands by receptors on the cell surface. Clathrins assemble in the polyhedral
lattice right on the cytosolic surface of the cell membrane, which helps to deform the mem‐
brane into a coated pit with a size about 100–150 nm [27]. This process is mediated by
GTPase dynamin. As the clathrin lattice formation continues, the pit becomes deeply invagi‐
nated until the vesicle fission occurs. In the next step of the CME pathway, the endocytosed
vesicles internalized from the plasma membrane are integrated into late endosomes and fi‐
nally transported to lysosomes.
CvME begins in a special flask-shaped structure on the cell membrane called caveola, which
is a kind of cholesterol- and sphingolipidrich smooth invagination [28]. CvME usually hap‐
pens in the vessel wall lining monolayer of endothelial cells [7]. Caveolae have a diameter
range of 50–100 nm [11] and are typically between 50 and 80 nmwith a neck of 10–50 nm [6].
CvME is also a type of cholesterol, dynamin-dependent, and receptor-mediated pathway
[29]. The fission of the caveolae from the membrane is mediated by the GTPase dynamin,
which locates in the neck of caveolae and then generates the cytosolic caveolar vesicle [11].
Some receptors located in caveolae, such as insulin receptors [30] and epidermal growth fac‐
tor receptor (a type of receptor in ovarian cancer) [31], can mediate CvME [32]. The vesicle
budding from the caveolae, a type of caveolin-1-containing endosome is called caveosome
[29]. The intracellular fate of the caveosome differs from that of CME. Compared with CME,
CvME is generally considered as a alternative pathway which can deliver the vectors into
Golgi and/or endoplasmic reticulum, thus avoiding the normal lysosomal degradation
Macropinocytosis is a type of distinct pathway that nonspecifically takes up a large amount
of fluid-phase contents through the mode called fluid-phase endocytosis (FPE) [33]. Macro‐
pinocytosis is a signal dependent process that normally occurs when macrophages or cancer
cells are in response to colony-stimulating factor-1 (CSF-1), epidermal growth factor (EGF)
and platelet-derived growth factor or tumor-promoting factor, such as phorbol myristate
acetate respectively [34-36]. However, this process occurs constitutively in antigen-present‐
ing cells [37]. Macropinocytosis occurs via the formation of actin-driven membrane protru‐
sions, which is similar to phagocytosis. However, in this case, the protrusions do not zipper
up the ligand-coated particle; instead, they collapse onto and fuse with the plasma mem‐
brane [11]. The macropinosomes have no apparent coat structures and are heterogenous in
size, but are generally considered larger than 0.2 μm in diameter [38, 39]. During this proc‐
ess, the small GTPase, Ras-related in brain (Rab) proteins are essential for the vesicle fission
from the cell membrane [40]. The relationship between the macropinocytosis and lysosome
is still unknown. This will be discussed later.
2.3. Non-endocytic pathways
There  are  three  technologies  that  are  designed  to  mediate  the  non-endocytic  pathways
and  successful  transfect  the  gene.  One  is  microinjection,  by  which  each  cell  is  injected
with  the  gene  materials  using  glass  capillary  pipettes.  The  second one  is  permeabiliza‐
tion by using pore-forming reagents  such as  streptolysin O or  anionic  peptides such as
HA2  subunit  of  the  influenza  virus  hemagglutinin.  The  third  one  is  electroporation,
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which uses an electric field to open pores in the cell. All of them are highly invasive and
not ideal for in vivo gene delivery.
However, There are evidences which can prove the existing of other non-endocytic path‐
ways. One pathway is related to the formation of holes in the cell membrane, called “pene‐
tration”. A class of cationic peptides with the protein transduction domains (PTDs), such as
TAT, has the ability to be taken up without endocytic events [41]. These peptides can direct‐
ly penetrate cell membranes in a receptor-, and energy-independent way. In 2004, Hong et
al. studied the hole formation on the cell membrane induced by poly(amidoamine) (PA‐
MAM). The results indicated that the hole formation can be induced by positively charged
PAMAM, and labeled PAMAM can diffuse into the cells through small holes in the mem‐
brane. This mechanism is considered a nonspecific pathway, which is not receptor-mediated
and lacks selective cellular uptake [42]. In 2010, Lee et al. used a PTD called Hph-1 to conju‐
gate vector PEI to deliver siRNA. The result showed that the complexes entered the cells
through the non-endocytic pathway, which has a quicker dynamic behavior compared with
the endocytosis pathways and is energy-independent because it has high transfection effi‐
ciency even in low temperature [43]. Another non-endocytic pathway is called “fusion”,
which is special for lipoplexes, as it can cause a direct release of DNA to the cytoplasm be‐
fore entering the endocytic pathways. However, more and more evidences suggest that fu‐
sion with the cell membrane contributes minimally to the overall uptake of lipoplexes, while
the CME plays an important role in the uptake of lipoplexes [44]. there have been few stud‐
ies on non-endocytic pathways, and more efforts are needed to have a comprehensive un‐
derstanding of these pathways for the improvement of non-viral gene delivery.
Pathways GTPases Relationship withlysosome Receptors
Phagocytosis Rho Dependent Dependent
CME Dynamin Dependent Dependent
CvME Dynamin Independent Dependent
Macropinocytosis Rab In dispute Non-specific
Non-endocytic Independent Independent Non-specific
Table 1. Cellular uptake mechanisms.
3. Factors that influence the uptake pathways of non-viral gene delivery
There are many factors that are involved in the selection of uptake pathways of non-viral
gene complexes. These factors include particle size, particle surface charge, particle shape,
cell type, and even culture condition. Because the complexes of non-viral gene vector/DNA
or siRNA are usually a group of heterogeneous particles with diverse sizes, surface charges,
and shapes, several uptake pathways may be involved in the internalization of one kind of
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complexes into a single cell type. For example, transfection by branched PEI25kDa/DNA
polyplexes was mediated by both CME and CvME pathways in HUH-7 and Hela cells [9].
Later, Hansjörg Hufnagel reported that the macropinocytosis is also very important for the
uptake of branched PEI25kDa/DNA polyplexes into Hela and CHO-1 cells due to the exis‐
tence of large particles of polyplexes (>500 nm) [12]. Therefore, the heterogeneity of com‐
plexes has to be taken into consideration when the results are analyzed. Particle size is a
very important factor for the pathway selection of complexes. As mentioned above, the la‐
beled cationic PAMAM can induce hole formation in the cell membrane. The holes induced
by PAMAM are 15–40 nm in diameter [42]. The particle including the gene complex, which
is smaller than these holes, can diffuse through the holes and be taken up by nonspecific
non-endocytic rather than specific receptor mediated endocytic pathways. PEI/DNA com‐
plexes with sizes smaller than 500 nm are mainly taken up by CME and CvME according to
a previous study [10]. While PEI/DNA complexes with sizes >500 nm are mainly internal‐
ized by macropinocytosis pathway [10].
The charge density of a complex is also an important factor for its uptake. The cell mem‐
brane consists of a bilayer of lipid and anionic membrane proteins. These anionic proteins
are very helpful to the uptake of cationic complexes. However, once the net positive charge
falls to neutral, the uptake efficiency will be inhibited a lot. This is because the neutral
charge density will weaken the interaction between complexes and membrane proteins, and
it will also increase the aggregation of complexes, which will make them large and hard to
be internalized. This change can be caused by the anionic proteins in the in vivo circulation
of blood, and the serum used in the in vitro transfection medium. The modification of poly‐
ethylene glycol (PEG) can solve this problem with its high hydrophilicity, electrical neutral‐
ity and steric-repulsive propensity [45].
As to the relationship between the shape of particles and the pathway selection, few studies
have been made about this issue. A group once reported that the uptake of protein-coated
spherical gold nanoparticles is more efficient than rod-shaped ones in Hela cells, SNB19
cells, and STO cells [46, 47]. However, as to the relationship of nonviral gene complexes and
their uptake efficiency, it is not easy to draw such a conclusion, because the non-viral gene
complexes are usually a group of nanoparticles with heterogeneous shapes, and their shapes
are dependent on the experimental conditions. Taking chitosan as an example, the fraction
of complexes that have nonaggregated, globular structures increases with increasing chain
length of the chitosan oligomer, increasing charge ratio and reduction of pH (from 6.5 to 3.5)
[48]. Because of this, this complicated issue leaves much room for researchers to discuss.
Cell type is another important factor that influences the pathway selection of non-viral gene
complexes. Different types of cells can take up a kind of complex in different pathways.
Most of the studies focused on COS-7 cells, which were used as a well-established model
cell for gene delivery researches [28]. Some researchers also used other cell lines such as
A549, Hela, and HUH-7 cells. Caveolae, which are a very important structure for CvME
pathway, are present in many cell types, but they are particularly abundant in the vessel
wall lining monolayer of endothelial cells. As a result, endothelial cells have been especially
used in studies on CvME pathway. A study tested the endocytosis pathways involved in the
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transfection of PEI/DNA complexes with different cell lines. The result showed that in
COS-7 cells, the clathrin-dependent pathway was the main contributor to the transfection
process for both linear and branch PEIs [9]. Another study suggests that macropinosomes
have a higher propensity to deliver PEI/DNA cargo than do endosomes in CHO and Hela
cells [12]. Therefore, different cell lines involve different endocytic pathways, and cell type is
the important factor that must be considered in such studies.
4. Tools for the study of uptake pathways
The study on the mechanisms of uptake pathways is important to the rational design of non-
viral gene vectors because this step can determine the intracellular fate of complexes. How‐
ever, because there are many factors that influence the pathway selection, how to conduct
these studies is also a very complicated problem that needs to be discussed in detail.
Inhibitors are the effective tools to block specific pathway in order to determine whether it
plays an important role in the uptake of complexes. However, none of the commonly used
inhibitors of different uptake pathways is absolutely specific. All of them either affect the
actin cytoskeleton with their side effects, or interfere with alternative uptake pathways si‐
multaneously. In addition, they usually show cell type variations. The scope of the usage of
commonly used inhibitors will be introduced according to the classification of uptake path‐
ways in the following paragraphs of this section. The most direct way to distinguish endo‐
cytic pathways and non-endocytic pathways is to use the inhibitor or method of energy
depletion, because most endocytic pathways are energy dependent. The commonly used in‐
hibitors and methods are: low temperature (4 °C) and sodium azide (an ATPase inhibitor).
Low temperature and ATP inhibitor should be used together in some conditions because
some of the non-endocytic pathways are also sensitive to low temperature [42, 49].
To distinguish the phagocytic and macropinocytic pathways with CME and CvME path‐
ways, the commonly used inhibitors and methods for phagocytic and macropinocytic path‐
ways are: inhibitors of sodium-proton exchange “amiloride and its derivatives”, F-
actindepolymerizing drugs “cytochalasin D and latrunculins”, inhibitors of
phosphoinositide metabolism “wortmannin and LY290042”, and protein kinase C activator
“phorbol esters”. Except phorbol esters, the specificity of all the inhibitors is still in doubt as
depolymerizing F-actin and inhibition of phosphoinositide metabolism may also disrupt the
other two endocytic pathways. For example, cytochalasin D is also used as the inhibitor for
CvME [50]. Within these inhibitors, amiloride and its derivatives may be considered as the
first choice for their fewest side effects. Rottlerin, a novel macropinocytosis inhibitor which
is rapid acting, irreversible, and selective, was discovered in 2005. In 2009, Hufnagel et al.
found that rottlerin can specifically inhibit the transfection efficiency of PEI (25 kDa)/DNA
complexes on Hela and CHO-K1 cells up to 50%, which verified the important role of FPE in
the non-viral gene delivery by PEI (25 kDa) [12].
The commonly used inhibitors and methods for clathrin-mediated endocytosis are: Hyper‐
tonic sucrose (0.4–0.5 M), potassium depletion, cytosolic acidification, chlorpromazine (50–
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100 μM), monodansylcadaverine (MDC), phenylarsine oxide. However, all of them have
been shown to be able to inhibit macropinocytosis, thus cannot be used to distinguish the
clathrin-mediated endocytic pathway and the macropinocytic pathway. Besides this, all
these inhibitors can influence the cortical actin cytoskeleton more or less, which can cause
non-specific cytotoxicity. However, potassium depletion, chlorpromazine, and MDC are the
relatively better choices than the other ones for the initial discrimination of clathrin-mediat‐
ed endocytic pathway [51].
As to caveolae-mediated endocytic pathway, the commonly used inhibitors and methods
are: statins, methyl-β-cyclodextrin (MβCD), filipin, nystatin, genestein, and cholesterol oxi‐
dase. Among them, the incubation with filipin, nystatin, and cholesterol oxidase produce
the fewest side effects. The chronic inhibition of cholesterol synthesis by statins or acute cho‐
lesterol depletion by MβCD nonspecifically disrupts intracellular vesicle trafficking and the
actin cytoskeleton. Also, the specificity of genestein is still in doubt for its nonspecific dis‐
ruption of the actin network. That being so, appropriate controls should be included when
filipin, nystatin, and cholesterol oxidase are used [51].
The inhibitors for the study of intracellular fates of complexes are also very important. Mon‐
ensin, bafilomycin A can inhibit the acidification of endosomes, thus preventing their matu‐
ration and fusion into lysosomes [52, 53]. Chloroquine is another inhibitor that accumulates
in endosomes/lysosomes and causes the swelling and disruption of endocytic vesicles by os‐
motic effects [21]. Last but not least, the cell-dependence of inhibitors should be noted when
experiments are carried out. For example, chlorpromazine treatment inhibited the uptake of
transferrin, a marker for CME by ~50% in D407 and HUH-7 cells. However, it showed no or
little significant inhibitory capacity in ARPE-19 and Vero cells or even an enhanced effect in
COS-7 cells [54, 55]. Therefore, a range of concentration with lowest cytotoxicity and suffi‐
cient inhibitory efficiency should be determined first when the inhibitor is used on the cell
for the first time. Then, the lack of absolute specificity can be compensated by the combined
application of biological methods such as siRNA silencing, transient or stable expression of
dominant-negative proteins, and reconstruction of proteins by knockout mutants, all of
which aremore specific than classical chemical inhibitors. For example, mutant dynamin has
been successfully used to prove the necessity of dynamin in the endocytic pathways of
transferrin receptors and EGF receptors [55]. A constitutive knockdown technique through
RNAi has been used to prove the role of an essential accessory protein “epsin” in the CME
pathway [56]. Another efficient way of making up the pitfalls of nonspecific inhibitors is the
combined usage of fluorescently labeled gene complexes and fluorescent probes that are
specifically internalized through certain uptake pathways.
Except  for  inhibitors,  molecular  probes  and  markers  are  also  important  tools  for  the
study of uptake pathways for non-viral gene complexes. They can be used together with
the classical chemical inhibitors or biological inhibitors to make the results more convinc‐
ing.  There are several  classical  molecular probes that are known to be specifically inter‐
nalized  through  each  uptake  pathway.  Transferrin  is  often  used  as  a  probe  of  CME
pathway in many studies [12, 57, 58]. Transferrin receptor (TFR) mediates transferrin up‐
take  by  CME,  so  that  it  can  be  used as  a  CME marker  and detected  by  anti-TFR [59].
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Cholera toxin beta subunit (CTBs) is commonly used as a probe for CvME [12, 57]. How‐
ever,  Lisa  et  al.  argued that  CTBs binds receptors  that  are  contained in  lipid-rich areas
and are internalized via a mechanism similar to CvME, because CTBs uptake is unaffect‐
ed by a clathrin inhibitor and 33% uptake remains after treatment with a specific caveola
inhibitor.  Therefore,  CTBs  may  enter  into  the  cells  via  another  unknown  clathrin-inde‐
pendent mechanism [60].  In addition,  caveolin-1 is  also an important marker for CvME,
as it is specifically involved in the formation of caveosome [29].
Dextran is the popular probe for macropinocytosis in some studies because it can accumu‐
late in the endo-lysosome compartment [57]. As to phagocytosis, large (2 μm) microspheres
are usually used as the probes. To solve the issue about the intracellular fate of complexes, a
group of the specific markers or biological dyes are necessary to colocalize the non-viral
gene complexes and intracellular organelles. TFR is used as a classical early endosome
marker because it is transported into an early endosome when transferrin is internalized.
EEA-1 is a hydrophilic peripheral membrane protein present in cytosol and membrane frac‐
tions. It colocalizes with TFR, and immunoelectron microscopy shows that it is associated
with tubulovesicular early endosomes [61]. The lysosome-associated type 1 membrane gly‐
coproteins LAMP-1 and LAMP-2 are localized primarily on the periphery of the lysosome,
and can be used as markers for lysosome [62, 63]. The different roles of EEA-1 and LAMP in
the endolysosome pathway allow us to know the stage in which the uptake carries on. Other
endosome or lysosome markers are the Rab family proteins. They are small GTPases that
control multiple membrane trafficking events in the cell, and there are at least 60 Rab genes
in the human genome [64]. Inside the Rab family, Rab5 and Rab7 are the most studied Rab
variants, in which Rab5 is found to be the marker for early endosomes as it in part controls
the invagination at the plasma membrane, endosomal fusion, motility, and signaling [63],
and Rab7 is found to be the marker for late endosomes and lysosomes as it controls the ag‐
gregation, fusion, and maintenance of perinuclear lysosome compartment [65].
Pathways inhibitors markers
Phagocytosis Amiloride, cytochalasin D, latrunculins,wortmannin, LY290042, sodium azide Large microspheres (2 μm)
CME Chlorpromazine, monodansylcadaverine,phenylarsine oxide, sodium azide
Transferrin, lactosylceramide,
TFR
CvME Filipin, nystatin, cholesterol oxidase, statins,genestein, MβCD, sodium azide CTBs, caveolin-1
Macropinocytosis Rottlerin, amiloride, cytochalasin D, latrunculins,wortmannin, LY290042, sodium azide Dextran
Table 2. Inhibitors and markers
The organelle specific dyes are other ideal tools for the detection of colocalization, and they
are relatively convenient. LysoTracker (red) and Lyso Sensor (green) are the widely used
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dyes for lysosomes. Cell light (red or green) are the widely used dyes for early endosomes.
Combined with the confocal imaging technology, the colocalization of labeled non-viral
gene complexes and intracellular compartments can be viewed intuitively. However, the
classical confocal imaging technology can only provide the monolayer images, the informa‐
tion from which is not convincing enough. A novel three dimensionally integrated confocal
technology is so strong that it can provide the intact information of a whole cell by scanning
layer by layer.
5. Application of cellular uptake mechanism.
Based on the current understanding of cellular uptake mechanisms, one can rationally de‐
sign vectors and improve their efficiency. Each pathway has advantages that need to be op‐
timized and disadvantages that should be avoided (Table 3).
Pathways Advantages Disadvantages
Phagocytosis Specific cell-type targetingSpecific receptors
Lysosome involved
In vivo clearance
CME Specific receptors Lysosome involved
CvME Bypass the lysosomeSpecific receptors
Membrane structure dependent
Slower cellular uptaking
Macropinocytosis Larger particles uptaking. Non-specific
Non-endocytic Bypass the lysosome Non-specific
Table 3. Characteristics of pathways.
5.1. Endo-lysosomal escape
Endo-lysosomal escape is one of the most crucial issues in non-viral vector design. Non-viral
delivery systems, such as polyplexes and lipoplexes, will be trapped and degraded in the
lysosomes if their cellular uptake pathways involve endo-lysosomes. As discussed above,
some of the uptake pathways involve endo-lysosomes, such as CME and phagocytosis.
CvME is known to bypass the endo-lysosomes. Similarly, macropinocytosis is known to not
have any associations with endo-lysosomes [66, 67], but some studies have suggested that it
involves lysosomes [67, 68]. These contradictory data may be dependent on cell type. Stimu‐
lating special pathway to bypass endo-lysosomes is a novel direction to improve efficiency.
This will be discussed later.
A non-viral delivery system uptaken by endo-lysosomes dependent pathways must be ca‐
pable of escaping endo-lysosomes. From early endosome to late endosome transport, a ma‐
turation process involving compartment acidification by proton pumps located on the
endosomal membrane exists. Some non-viral vectors exhibit the ability to escape the endo-
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lysosome, called proton sponge, such as PEI [10, 69, 70]. PEI contains a nitrogen atom that can
be protonated, and this serves to consume endosomal protons because endosomes acidify
their microenvironment. As a result, an increase in endosomal chloride anion, which diffus‐
es into the endosomes with the protons, leads to an increase in osmotic pressure, thus induc‐
ing osmotic swelling [69]. Therefore, the endosome might break down and release PEI. This
mode of action has been widely incorporated in recent non-viral vector designs. However, a
pDAMA-based vector with endosomal buffering capacity has been reported to show no en‐
dosomal escape activity in cell-based assay, indicating that the proton sponge hypothesis
may not be applicable in some cases. These findings warrant further elucidation and investi‐
gation of the mechanism of non-viral gene delivery [71].
For lipoplexes, the cationic liposome can interact with the anionic cytoplasmic facing mono‐
layer lipid of endosome and release the DNA from the endosome through the flip-flop
mechanism [72]. 1,2-Dioleoylsn-glycero-3-phosphatidylethanolamine (DOPE), the pH-sensi‐
tive fusogenic lipid additive, is very helpful to the displacement of the anionic lipds from
the cytoplasm-facingmonolayer of the endosomal membrane to the opposite direction via a
flip-flop mechanism. However, the serum components are known to inactivate and destabi‐
lize the lipoplex structures that contain DOPE [73].
Viruses  have  the  ability  to  destabilize  the  endosomal  membrane,  which  explains  why
many proteins from different viruses are being used [69].  Some viruses are well  known
to use fusogenic peptides to cross the endosomal membrane and reach the cytosol  [21].
The  process  by  which  viruses  destabilize  endosomal  membranes  in  an  acidification-de‐
pendent manner has been mimicked with synthetic peptides containing the amino-termi‐
nal 20-amino-acid sequence of the influenza virus HA [70]. Generally, short sequences of
only 20 amino acids are needed for membrane destabilization,  and they usually contain
a high content of basic residues [74].
Cell-penetrating peptides (CPPs) are used to enhance endosomal escape. The HIV-1 Tat pro‐
tein is the first CPP to be discovered. It transactivates the transcription of the HIV-1 genome,
has been observed to cross the plasma membrane by itself, leading to the identification of a
peptide fragment (49–59 amino acids) that confers cell permeability to the protein (Tat pep‐
tide), and is one of the better characterized CPPs [75]. Most of the CPPs contain a high densi‐
ty of basic amino acids (arginines and/orlysines), which are proposed to interact with the
anionic surface of the plasma membrane and enhance internalization of the peptides [75].
These peptides adopt an a -helical structure at endosomal pH leading to hydrophobic and
hydrophilic faces that can interact with the endosomal membrane to cause disruption and
pore formation [74].
5.2. Optimization of CvME
CvME is considered an alternative pathway that can bypass the endo-lysosomes. As gene
materials will not be degraded in the lysosomal compartments, we can take advantage of
CvME to improve the efficiency of transfection. For example, Nathan P. et al. targeted com‐
plexes (PEI–DNA) in CvME and CME with folic acid and transferrin, respectively; however,
only vectors via CvME successfully delivered genes, as CvME is avoidant of lysosomes.
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These data demonstrate that the uptake mechanism and subsequent endocytic processing
are important design parameters for gene delivery materials [76]. However, the key is con‐
trolling the uptake mechanism.
Particle size is a very important factor for uptake mechanisms. In a previous study, three
particles (20, 40, and 100 nm) were investigated for their uptake efficiency via CvME in en‐
dothelial cells. The results showed that the uptake efficiency levels of the 20- and 40-nm
nanoparticles were 5–10 times greater than that of the 100-nm particles [6], indicating that
small particles can be uptaken by CvME more efficiently compared with large ones. Howev‐
er, another study found that the uptake of microspheres with a diameter <200 nm in non-
phagocytic B16 cells involved CME. With increasing size, a shift to a mechanism that relied
on a caveolae-mediated pathway became apparent, which became the predominant path‐
way of entry for particles measuring 500 nm in size [77]. This can be attributed to the fact
that the mechanism of CvME is cell type dependent in some cases. According to the target
cell type, the mechanism must be fully studied before designing a vector.
CvME is a kind of receptor-mediated endocytosis pathway. As a result, some specific li‐
gands can mediate CvME via ligand–receptor binding. The insulin receptor [30], epidermal
growth factor (EGF) receptor [31], transforming growth factor beta (TGFbeta) receptor [78]
have been found to mediate this pathway. Another study used the cyclic Asn–Gly–Arg pep‐
tide to enhance gene transfection efficiency in CD13-positive vascular endothelial cells via
CvME [79]. However, cyclic RGD ligands have been reported to facilitate CvME of thiolated
c(RGDfK)-polyethylene glycol (PEG)-b-PLL micelles without high endosomal-disrupting
properties and thus improve transfection efficiency [80]. The cyclic RGD peptide ligands
c(RGDfK) can selectively recognize αvβ3 and αvβ5 integrin receptors on the cell surface.
The receptors can mediate CvME and bypass endo-lysosomes. The αvβ3 and αvβ5 integrin
receptors overexpressed on endothelial cells of tumor capillaries and neointimal tissues. As
a result, the vectors with cyclic RGD peptide ligands can be used for cancer gene therapy.
Cellular stress can also be used to control the cellular uptake mechanism. Heat shock and
hyperosmotic shock can stimulate caveolin internalization [81]. Recent research has shown
that hypertonic exposure of alveolar cells caused down-regulation of CME and fluid-phase
endocytosis while stimulating CvME. An osmotic polymannitol-based gene transporter that
can increase caveolae-mediated endocytosis was designed taking advantage of this mecha‐
nism [82]. The possible mechanisms have been discussed. Non-penetrating osmolytes tend
to draw water from the intracellular space through an osmotic gradient, cause cell hyperton‐
ic stress accompanied by cell shrinkage. Responding the cellular hypertonic stress, phos‐
phorylation of caveolin-1 is mediated by Src-kinase. Src-kinase-mediated phosphorylation
of caveolin-1 is required for caveolae budding. Finally the CvME is stimulated.
5.3. Inhibition of phagocytosis
After in vivo administration, the non-viral delivery system can be uptaken by macrophag‐
es and then cleared. This macrophage clearance effect mainly via phagocytosis is one of
the  main  barriers  for  non-viral  gene  delivery.  Numerous  methods  are  used  to  avoid
phagocytosis of macrophages in vector design. Antibodies are being widely used for tar‐
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geting  non-viral  gene  delivery.  However,  the  constant  fragments  can  be  recognized  by
phagocytosis and then uptaken by macrophages. Therefore, antibodies that lack constant
fragments are sometimes used to help non-viral  vectors avoid recognition and clearance
by macrophages in vivo [83].
Other vectors can also be recognized by macrophages. As discussed above, some cationic
polyplexes or lipoplexes will be tagged by some opsonins and then recognized in vivo. PE‐
Gylation is widely used to avoid the in vivo clearance effect by phagocytosis. The highly hy‐
drophilic nature of PEG produces a hydration shell around its conjugated partner, hence
reducing intermolecular interactions and, consequently, toxicity [84]. As an effect of reduc‐
ing intermolecular interactions, PEGylation can effectively avoid phagocytosis; moreover, in
vivo studies have reported on long circulating half-life of PEGylated vectors [85].
However, some studies have shown that PEGylation can reduce the efficiency of vectors [84]
possibly because PEGylation may inhibit cellular uptake and endosomal escape of the vec‐
tors. One study compared non-PEGylated and PEGylated liposomes, with the data showing
that PEGylated liposomes have poor endosomal escape capability as non-PEGylated lipo‐
somes can escape from endosome efficiently [86]. The inhibitory effects of PEGylation de‐
pend on some factors. A study about PEGylated cationic liposomes demonstrated that acid-
labile PEGylation liposomes have higher transfection efficiency than acid-stable PEGylation
ones, which can be ascribed to the more efficient endosomal escape activity of acid-labile
PEGylation liposomes [87]. The possible mechanism involved here is that the PEG of acid-
labile PEGylation liposomes can be cleaved under low pH (endosomal compartments), al‐
lowing the vector to fully interact with the endosomal membrane. So other biodegradable
shielding methods should be better than classical PEGylation. According to this hypothesis,
recently, an alternative to PEGylation was designed. This work reports, for the first time, the
use of hydroxyethyl starch (HES) for the controlled shielding/deshielding of polyplexes.
Non-viral delivery systems can be protected by HES shielding, and the HES can then be de‐
graded in vivo, indicating that HES shielding has less influence on the efficiency of vectors
compared with PEGylation [88].
6. Conclusion
In summary, cellular uptake is the most important intracellular process. Understanding cel‐
lular uptake mechanisms is essential to determining the limits of gene delivery. Different
pathways have different intracellular fates. Some vectors can enter cells via endo-lysosomal
pathways. Thus, some methods have to be used to protect genes against degradation in ly‐
sosomes. Optimizing CvME can successfully deliver genes by avoiding endo-lysosomes.
Each pathway has its own disadvantages, and learning how to inhibit certain pathways is
significant in some cases. In conclusion, taking advantage of cellular uptake mechanisms
and knowing how to control them hold considerable potential for improving the efficiency
of gene delivery.
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